SCHEMBL845290

SCHEMBL845290

COc1ccc(C)cc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3cc(C)ccc3OC)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 3/20 0.52
HCRTR2 O43614 3/20 0.52
ALDH1A1 P00352 4/20 0.50
MAPK1 P28482 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
TSHR P16473 1/20 0.50
MAPT P10636 1/20 0.50
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
HTT P42858 1/20 0.48
ROCK2 O75116 1/20 0.47
LMNA P02545 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845539 0.95 HCRTR1 (0.54) HCRTR1HCRTR2ALDH1A1MAPK1SMN1; SMN2
SCHEMBL845629 0.94 TSHR (0.50) HCRTR1HCRTR2ALDH1A1MAPK1SMN1; SMN2
SCHEMBL845002 0.92 CYP2C9 (0.55) HCRTR1HCRTR2ALDH1A1MAPK1SMN1; SMN2
SCHEMBL873856 0.91 HCRTR1 (0.45) HCRTR1HCRTR2ALDH1A1MAPK1SMN1; SMN2
SCHEMBL845000 0.91 RHOC (0.51) ALDH1A1MAPK1SMN1; SMN2TSHRMAPT
SCHEMBL845284 0.89 MAPK1 (0.58) ALDH1A1MAPK1MEN1KMT2ACYP2C9
SCHEMBL873577 0.84 LMNA (0.47) HCRTR1HCRTR2ALDH1A1MAPK1SMN1; SMN2
SCHEMBL845641 0.84 MAPK1 (0.53) ALDH1A1MAPK1MEN1KMT2ACYP2C9
SCHEMBL13272181 0.84 MAPK1 (0.53) ALDH1A1MAPK1MEN1KMT2ACYP2C9
SCHEMBL845871 0.83 KMT2A (0.48) HCRTR1HCRTR2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed